Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovate (VATE) Asset Writedowns and Impairment (2016 - 2024)

Historic Asset Writedowns and Impairment for Innovate (VATE) over the last 15 years, with Q4 2024 value amounting to $100000.0.

  • Innovate's Asset Writedowns and Impairment fell 9166.67% to $100000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $1.9 million, marking a year-over-year increase of 555.56%. This contributed to the annual value of $100000.0 for FY2024, which is 9444.44% down from last year.
  • As of Q4 2024, Innovate's Asset Writedowns and Impairment stood at $100000.0, which was down 9166.67% from $1.2 million recorded in Q4 2023.
  • Innovate's 5-year Asset Writedowns and Impairment high stood at $11.1 million for Q3 2020, and its period low was $100000.0 during Q1 2020.
  • Over the past 5 years, Innovate's median Asset Writedowns and Impairment value was $100000.0 (recorded in 2020), while the average stood at $1.4 million.
  • Within the past 5 years, the most significant YoY rise in Innovate's Asset Writedowns and Impairment was 200000.0% (2021), while the steepest drop was 9600.0% (2021).
  • Innovate's Asset Writedowns and Impairment (Quarter) stood at $2.5 million in 2020, then plummeted by 96.0% to $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022, then surged by 1100.0% to $1.2 million in 2023, then tumbled by 91.67% to $100000.0 in 2024.
  • Its last three reported values are $100000.0 in Q4 2024, $1.2 million for Q4 2023, and $500000.0 during Q3 2023.